Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia

Bone Marrow Transplantation

Volumn 17, Issue 1, 1996, Pages 31-37

  Locatelli, F ^a   Pession, A ^b   Zecca, M ^a   Bonetti, F ^a   Prete, L ^b   Carra A M ^a   Prete, A ^b   Montagna, D ^a   Comoli, P ^a   Taibi, R M ^a   Paolucci, G ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Allogeneic bone marrow transplantation; Childhood acute leukemia; G CSF; Hematopoietic recovery

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CIPROFLOXACIN; COLISTIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; NYSTATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; VINCRISTINE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHRONIC LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HLA MATCHING; HOSPITALIZATION; HUMAN; HUMAN CELL; INFANT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SIBLING; SURVIVAL;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEALTH CARE COSTS; HEMATOPOIESIS; HUMANS; INFANT; LEUKEMIA; MALE; RECOMBINANT PROTEINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 13344270912     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
2. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844-2853.
3. Lieschke GJ, Burgees AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (second of two parts). New Engl J Med 1992; 327: 99-106.
4. Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; ii: 891-895.
5. Taylor K, Jagannath S, Spitzer G et al. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 1989; 7: 1791-1799.
6. Linch DC, Scarffe H, Proctor S et al. A randomised vehicle controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant 1993; 11: 307-311.
7. Gisselbrecht C, Prentice HG, Bacigalupo A et al. Placebo-controlled phase I/II trial of lenograstim in bone-marrow transplantation. Lancet 1994; 343: 696-700.
8. Masaoka T, Yakaku F, Kato S et al. Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol 1989; 17: 1047-1050.
9. Schriber JR, Chao NJ, Long GD et al. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Blood 1994; 84: 1680-1684.
10. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
11. Willemze R, Richel DJ, Falkenburg JHF et al. In vivo use of CAMPATH-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation. Bone Marrow Transplant 1992; 9: 255-259.
12. Locatelli F, Pession A, Bonetti F et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994; 8: 844-849.
13. Boerwinkle E, Xiong W, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 1989; 86: 212-216.
14. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
15. Shulman HM, Sullivan KM, Waiden PL et al. Chronic graft-versus-host syndrome in man. Am J Med 1980; 69: 204-217.
16. Shapiro SS, Wilk MB. An analysis of variance test for normality. Biometrica 1965; 52: 591-599.
17. Barnes R. Infections following bone marrow transplantation. In: Treleaven J, Barren AJ (eds). Bone Marrow Transplantation in Practice. Churchill Livingstone: Edinburgh, 1992, pp 281-282.
18. Nemunaitis J, Rabinowe SN, Singer JW et al. Recombinant granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid cancer. New Engl J Med 1991; 324: 1773-1778.
19. Powles R, Smith C, Milan S et al. Human recombinant GM-CSF in allogeneic bone marrow transplant for leukemia: double-blind placebo controlled trial. Lancer 1990; 336: 1417-1420.
20. Nemunaitis J, Buckner CD, Appelbaum FR et al. Phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 1991; 77: 2065-2071.
21. o and entry into the cell cycle of primitive human hematopoietic progenitors. Proc Natl Acad Sci USA 1992; 89: 4013-4017.
22. Bolwell BJ, Goormastic M, Yanssens T et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913-918.
23. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
24. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-598.
25. Teshima H, Ishikawa J, Kitayama H et al. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. Exp Hematol 1989; 17: 853-858.
26. Giralt S, Escudier S, Kantarjian H et al. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. New Engl J Med 1993; 329: 757-761.
27. Viret F, Molina L, Plantaz D et al. Impact of delayed start (day +5) G-CSF after allogeneic bone marrow transplantation: a pilot study. Blood 1994; 89 (suppl. 1): 95a.